Research To Practice | Oncology Videos

Latest Episodes:

First-Line and Maintenance Therapy for Patients with Extensive-Stage Small Cell Lung Cancer — An Interview with Prof Martin Reck Jun 18, 2026

Show notes

Featuring an interview with Prof Martin Reck, including the following topics:

Case: A woman in her mid 70s with extensive-stage small cell lung cancer (ES-SCLC) experiences a strong response to first-line chemoimmunotherapy and maintenance lurbinectedin/atezolizumab (0:00)
Biology of small cell lung cancer and pharmacodynamics of systemic treatment (3:25)
Considerations with maintenance therapy for ES-SCLC (9:31)
Considerations with immunotherapy for ES-SCLC (13:12)
Curability of SCLC with systemic therapy (15:17)
Data with chemoimmunotherapy for patients with poor performance status (25:55)
Future developments in therapy for SCLC (30:11)
Rapid fire: Small Cell 101 (35:45)

CME information and select publications

Urothelial Bladder Cancer — Fifth Annual National General Medical Oncology Summit Jun 18, 2026

Show notes

Featuring perspectives from Dr Terence Friedlander and Dr Daniel P Petrylak, including the following topics:

Introduction (0:00)
Role of Immunotherapeutic Strategies in the Management of Nonmetastatic Urothelial Bladder Cancer (UBC); Emerging Utility of Circulating Tumor DNA Evaluation — Dr Friedlander (3:53)
Other Novel Agents and Strategies for Nonmetastatic and Metastatic UBC — Dr Petrylak (26:41)

CME information and select publications

HER2-Positive Gynecologic Cancers — Proceedings from a Session Held During the Society of Gynecologic Oncology 2026 Annual Meeting on Women's Cancer Jun 17, 2026

Show notes

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topics:

Introduction (0:00)
Strategies to Identify Patients with HER2-Positive Gynecologic Cancers — Dr Liu (2:52)
Available Data with and Practical Application of HER2-Targeted Therapy in Advanced Gynecologic Cancers — Dr Slomovitz (25:16)
Identification and Management of Adverse Events with Trastuzumab Deruxtecan — Dr O'Malley (1:00:31)

CME information and select publications

Chronic Lymphocytic Leukemia — Fifth Annual National General Medical Oncology Summit Jun 16, 2026

Show notes

Featuring perspectives from Dr John N Allan and Dr Adam Kittai, including the following topics:

Introduction (0:00)
Current Management of Newly Diagnosed Chronic Lymphocytic Leukemia — Dr Allan (8:47)
Noncovalent Bruton Tyrosine Kinase Inhibitors and Other Novel Strategies — Dr Kittai (38:14)

CME information and select publications

Prostate Cancer — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting Jun 16, 2026

Show notes

Featuring perspectives from Dr Neeraj Agarwal, Dr Elisabeth I Heath, Dr Daniel P Petrylak, Dr Fred Saad and Dr Neal D Shore, moderated by Dr Heath, including the following topics:

Introduction (0:00)
Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Shore (2:12)
Current Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Petrylak (27:54)
Current and Future Role of PARP Inhibitors for Metastatic Prostate Cancer (mPC) — Dr Agarwal (50:49)
Emerging Role of AKT Inhibition for Patients with mHSPC — Dr Heath (1:13:12)
Current and Future Use of Radiopharmaceuticals for mPC — Dr Saad (1:37:26)

CME information and select publications

Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Fifth Annual National General Medical Oncology Summit Jun 15, 2026

Show notes

Featuring perspectives from Dr Manali Kamdar, Dr Krish Patel and Dr Gilles Salles, including the following topics:

Introduction (0:00)
Antibody-Drug Conjugates and Other Novel Strategies for the Management of Diffuse Large B-Cell Lymphoma (DLBCL) — Prof Salles (7:05)
Current and Future Role of Monoclonal and Bispecific Antibodies in the Management of DLBCL — Dr Patel (26:21)
Chimeric Antigen Receptor (CAR) T-Cell Therapy for DLBCL — Dr Kamdar (43:12)
CAR T-Cell Therapy for Follicular Lymphoma (FL) — Prof Salles (1:08:33)
Other Approved and Emerging Novel Therapies for FL — Dr Patel (1:24:44)
Integrating Bispecific Antibodies into the Management of FL — Dr Kamdar (1:41:34)

CME information and select publications

Pancreatic Cancer — Fifth Annual National General Medical Oncology Summit Jun 15, 2026

Show notes

Featuring perspectives from Dr Eileen M O'Reilly and Dr Philip A Philip, including the following topics:

Introduction (0:00)
Optimal Incorporation of Chemotherapy into the Management of Advanced Pancreatic Cancer — Dr Philip (7:27)
Other Available and Emerging Novel Approaches for Pancreatic Cancer — Dr O'Reilly (28:05)

CME information and select publications

Localized Renal Cell Carcinoma — Proceedings from a Session Held in Conjunction with the 2026 American Urological Association Annual Meeting Jun 13, 2026

Show notes

Featuring perspectives from Dr Thomas E Hutson, Dr Erik A Singer and Dr Ulka Vaishampayan, moderated by Dr Hutson, including the following topics:

Introduction (0:00)
Current Indications for Adjuvant Immune Checkpoint Inhibitor Therapy in the Management of Renal Cell Carcinoma (RCC) — Dr Singer (2:32)
Potential Role of Hypoxia-Inducible Factor-2 Alpha Inhibitors as a Component of Adjuvant Treatment — Dr Hutson (30:53)
Tolerability of Current and Emerging Adjuvant Approaches for RCC — Dr Vaishampayan (1:06:37)

CME information and select publications

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy Jun 11, 2026

Show notes

Featuring perspectives from Dr Sara A Hurvitz and Dr Virginia Kaklamani, including the following topics:

Introduction: Which Biomarkers and When (0:00)
Optimizing First-Line Therapy for Patients with Hormone Receptor (HR)-Positive Metastatic Breast Cancer (mBC) (5:31)
SERENA-6 Trial (19:44)
Inavolisib (23:08)
Management of HR-Positive mBC Progressing on a CDK4/6 Inhibitor and Endocrine Therapy (31:46)
Selective Estrogen Receptor Degraders (41:15)
AKT (46:13)

CME information and select publications

Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances Jun 09, 2026

Show notes

Featuring perspectives from Dr Christine L Hann and Dr Jacob Sands, including the following topics:

Introduction: Biopharmacology of Small Cell Lung Cancer — "Wildfire sparked in dry grass" (0:00)
Limited-Stage Disease (9:22)
Extensive-Stage Disease (16:23)
Paraneoplastic Syndromes — Lambert-Eaton Myasthenic Syndrome (23:54)
Bispecific T-Cell Engagers — Tarlatamab (30:00)
Antibody-Drug Conjugates — Ifinatamab Deruxtecan (39:19)
Other Novel Agents — Alisertib, Chimeric Antigen Receptor T-Cell Therapy (52:54)

CME information and select publications